Inhibitors of ROPN1L function by targeting key regulatory proteins involved in the phosphorylation processes that are essential for its activation and subsequent functional activity. Compounds that act as potent kinase inhibitors can effectively block protein kinase C, a pivotal kinase in the phosphorylation cascade that directly influences ROPN1L activity. This blockade results in the decreased activation of ROPN1L, as its functional state is contingent upon proper phosphorylation. Selective inhibitors of protein kinase C, by focusing on specific isoforms of the kinase, provide a more targeted approach to diminishing ROPN1L activity without affecting a wide range of kinases. This specificity ensures that the inhibition has a more direct impact on ROPN1L, thereby reducing its functional activity with a higher degree of precision.
Furthermore, broad-spectrum kinase inhibitors encompass a range of protein kinases beyond protein kinase C, extending the inhibition to other kinases that may also play a role in the activation of ROPN1L. Such inhibitors may also affect the beta isoform of protein kinase C, which has been implicated in ROPN1L regulation, thus causing a further decrease in ROPN1L activity. Additionally, interference with fatty acid metabolism can indirectly affect protein kinase C activity, suggesting that molecules disrupting these metabolic pathways could also lead to a reduction in ROPN1L phosphorylation and activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that blocks protein kinase C, which is involved in the phosphorylation of ROPN1L leading to its activation. Inhibition of protein kinase C thus decreases ROPN1L functional activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Selective protein kinase C inhibitor that reduces ROPN1L phosphorylation and subsequent activation, thereby decreasing its functional activity. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
A broad-spectrum protein kinase C inhibitor that can diminish the phosphorylation and thus the function of ROPN1L by limiting its activation. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
A selective inhibitor of protein kinase C, which is necessary for ROPN1L activation through phosphorylation, resulting in reduced ROPN1L activity. | ||||||
Calphostin C | 121263-19-2 | sc-3545 sc-3545A | 100 µg 1 mg | $343.00 $1642.00 | 20 | |
A potent and selective protein kinase C inhibitor that prevents ROPN1L phosphorylation, thus decreasing its functional activity. | ||||||
Ro 31-8220 | 138489-18-6 | sc-200619 sc-200619A | 1 mg 5 mg | $92.00 $245.00 | 17 | |
An inhibitor of protein kinase C that consequently reduces ROPN1L activation and function by inhibiting the phosphorylation process central to ROPN1L activity. | ||||||
LY-333,531 Hydrochloride | 169939-93-9 | sc-364215 sc-364215A | 1 mg 5 mg | $94.00 $287.00 | 6 | |
A selective inhibitor of protein kinase C beta isoform, which is involved in ROPN1L regulation, leading to decreased ROPN1L activity. | ||||||
Enzastaurin | 170364-57-5 | sc-364488 sc-364488A sc-364488B | 10 mg 50 mg 200 mg | $259.00 $612.00 $1721.00 | 3 | |
A protein kinase C beta inhibitor that reduces signaling pathways essential for ROPN1L activity, resulting in decreased ROPN1L function. | ||||||
Sotrastaurin | 425637-18-9 | sc-474229 sc-474229A | 5 mg 10 mg | $300.00 $540.00 | ||
A selective protein kinase C inhibitor that diminishes ROPN1L phosphorylation and activation, thereby reducing its functional activity. | ||||||
K-252a | 99533-80-9 | sc-200517 sc-200517B sc-200517A | 100 µg 500 µg 1 mg | $129.00 $214.00 $498.00 | 19 | |
An indolocarbazole that acts as a potent inhibitor of protein kinases, including those that regulate ROPN1L phosphorylation, thereby reducing ROPN1L activity. | ||||||